Global Molecular Diagnostics Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Molecular Diagnostics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Real Time- PCR Systems
- 1.4.3 Liquid Handling System
- 1.4.4 NA Extraction System
- 1.5 Market by Application
- 1.5.1 Global Molecular Diagnostics Market Share by Application (2014-2025)
- 1.5.2 Hospitals
- 1.5.3 Diagnostic Laboratories
- 1.5.4 Academic and Research Institutes
- 1.5.5 Pharmaceutical and Biotechnology Companies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Molecular Diagnostics Market Size
- 2.2 Molecular Diagnostics Growth Trends by Regions
- 2.2.1 Molecular Diagnostics Market Size by Regions (2014-2025)
- 2.2.2 Molecular Diagnostics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Molecular Diagnostics Market Size by Manufacturers
- 3.1.1 Global Molecular Diagnostics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Molecular Diagnostics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.2 Molecular Diagnostics Key Players Head office and Area Served
- 3.3 Key Players Molecular Diagnostics Product/Solution/Service
- 3.4 Date of Enter into Molecular Diagnostics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Molecular Diagnostics Market Size by Type (2014-2019)
- 4.2 Global Molecular Diagnostics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Molecular Diagnostics Market Size (2014-2019)
- 5.2 Molecular Diagnostics Key Players in United States
- 5.3 United States Molecular Diagnostics Market Size by Type
- 5.4 United States Molecular Diagnostics Market Size by Application
6 Europe
- 6.1 Europe Molecular Diagnostics Market Size (2014-2019)
- 6.2 Molecular Diagnostics Key Players in Europe
- 6.3 Europe Molecular Diagnostics Market Size by Type
- 6.4 Europe Molecular Diagnostics Market Size by Application
7 China
- 7.1 China Molecular Diagnostics Market Size (2014-2019)
- 7.2 Molecular Diagnostics Key Players in China
- 7.3 China Molecular Diagnostics Market Size by Type
- 7.4 China Molecular Diagnostics Market Size by Application
8 Japan
- 8.1 Japan Molecular Diagnostics Market Size (2014-2019)
- 8.2 Molecular Diagnostics Key Players in Japan
- 8.3 Japan Molecular Diagnostics Market Size by Type
- 8.4 Japan Molecular Diagnostics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Molecular Diagnostics Market Size (2014-2019)
- 9.2 Molecular Diagnostics Key Players in Southeast Asia
- 9.3 Southeast Asia Molecular Diagnostics Market Size by Type
- 9.4 Southeast Asia Molecular Diagnostics Market Size by Application
10 India
- 10.1 India Molecular Diagnostics Market Size (2014-2019)
- 10.2 Molecular Diagnostics Key Players in India
- 10.3 India Molecular Diagnostics Market Size by Type
- 10.4 India Molecular Diagnostics Market Size by Application
11 Central & South America
- 11.1 Central & South America Molecular Diagnostics Market Size (2014-2019)
- 11.2 Molecular Diagnostics Key Players in Central & South America
- 11.3 Central & South America Molecular Diagnostics Market Size by Type
- 11.4 Central & South America Molecular Diagnostics Market Size by Application
12 International Players Profiles
- 12.1 Agilent Technologies
- 12.1.1 Agilent Technologies Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Molecular Diagnostics Introduction
- 12.1.4 Agilent Technologies Revenue in Molecular Diagnostics Business (2014-2019)
- 12.1.5 Agilent Technologies Recent Development
- 12.2 BD
- 12.2.1 BD Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Molecular Diagnostics Introduction
- 12.2.4 BD Revenue in Molecular Diagnostics Business (2014-2019)
- 12.2.5 BD Recent Development
- 12.3 Bio-Rad Laboratories
- 12.3.1 Bio-Rad Laboratories Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Molecular Diagnostics Introduction
- 12.3.4 Bio-Rad Laboratories Revenue in Molecular Diagnostics Business (2014-2019)
- 12.3.5 Bio-Rad Laboratories Recent Development
- 12.4 Danaher Corporation
- 12.4.1 Danaher Corporation Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Molecular Diagnostics Introduction
- 12.4.4 Danaher Corporation Revenue in Molecular Diagnostics Business (2014-2019)
- 12.4.5 Danaher Corporation Recent Development
- 12.5 F. Hoffmann-La Roche
- 12.5.1 F. Hoffmann-La Roche Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Molecular Diagnostics Introduction
- 12.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Business (2014-2019)
- 12.5.5 F. Hoffmann-La Roche Recent Development
- 12.6 Eppendorf
- 12.6.1 Eppendorf Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Molecular Diagnostics Introduction
- 12.6.4 Eppendorf Revenue in Molecular Diagnostics Business (2014-2019)
- 12.6.5 Eppendorf Recent Development
- 12.7 PerkinElmer
- 12.7.1 PerkinElmer Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Molecular Diagnostics Introduction
- 12.7.4 PerkinElmer Revenue in Molecular Diagnostics Business (2014-2019)
- 12.7.5 PerkinElmer Recent Development
- 12.8 Tecan Group
- 12.8.1 Tecan Group Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Molecular Diagnostics Introduction
- 12.8.4 Tecan Group Revenue in Molecular Diagnostics Business (2014-2019)
- 12.8.5 Tecan Group Recent Development
- 12.9 Thermo Fisher Scientific
- 12.9.1 Thermo Fisher Scientific Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Molecular Diagnostics Introduction
- 12.9.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Business (2014-2019)
- 12.9.5 Thermo Fisher Scientific Recent Development
- 12.10 QIAGEN N.V.
- 12.10.1 QIAGEN N.V. Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Molecular Diagnostics Introduction
- 12.10.4 QIAGEN N.V. Revenue in Molecular Diagnostics Business (2014-2019)
- 12.10.5 QIAGEN N.V. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes.
The basic components of these systems include thermal cycler for automating the temperature cycling required in the PCR; optical systems for detection; and software to control the instrument and analyze the data. Liquid handling systems are used to dispense selected quantity of reagents, liquids, or samples to a container. These systems work on the principle of suction and are available as single or multi-channel systems. DNA Extraction systems are employed for streamlining the process of DNA extraction and automatic extraction of DNA from a variety of samples. These systems are employed as they are less time consuming, more efficient than the manual methods, and less prone to analytical errors.
In 2018, the global Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Diagnostics development in United States, Europe and China.
The key players covered in this study
Agilent Technologies
BD
Bio-Rad Laboratories
Danaher Corporation
F. Hoffmann-La Roche
Eppendorf
PerkinElmer
Tecan Group
Thermo Fisher Scientific
QIAGEN N.V.
Market segment by Type, the product can be split into
Real Time- PCR Systems
Liquid Handling System
NA Extraction System
Market segment by Application, split into
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Molecular Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Molecular Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.